Clinical Trials Browser

Active not recruiting × Immune Checkpoint Inhibitors × 90 days × Clear all

NCT05615142 2026-05-11

Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.

Phase 1 Active not recruiting

NSCLC

NCT07541755 2026-04-21

PD1-VEN-CAG

Phase 3 Active not recruiting

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma